超聲內(nèi)鏡下選擇性食管胃靜脈曲張來源支穿刺組織膠封閉術(shù)與傳統(tǒng)內(nèi)鏡治療的隨機對照研究
Abstract:ObjectiveToinvestigatethesafetyand eficacyof puncturecyanoacrylateselectiveseal(PCSS)underendoscopic ultrasound inthetreatmentofgastroesophageal varices(GOV).MethodsAtotalof10patientswith livercirrhosiswho underwentendoscopictherapyforthesecondarypreventionofGOVbleeding inBeijingDitan Hospital,,CapitalMedicalUniversity, from March1to December31,2023 were enroledandrandomlydivided intoPCSS groupandtraditional endoscopygroup.The patients werefolowedupfor6monthsaftersurgery,andthetwogroups werecomparedintermsofclinical outcomeand complications.The primaryoutcome measure wastherateof allviationordisappearanceofGOV,and thesecondaryoutcome measure was variceal rebleeding and death.The independent-samples t test was used for comparison of normally distributed or aproximatelynormall distributedquantitativedatabetweentwogoups,and the Wilcoxon non-parametric test wasused for comparisonofnon-normalldistributedquantitativedatabetweentwogroups;thechi-squaretestortheFisher’sexacttestwasused forcomparisonof qualitative data between two groups.ResultsThere were 50 patients inthe PCSS group,among whomlpatient waslosttofollow-up,andtherewere5Opatients inthetaditionalendoscopygoup,mong whom3patients werelosttofollow-up. There werenosignificantdiferencesbetweenthetwo groups inbaselinedatasuchasage,sex,Child-Pughclass,varices grade, and GOV typing(all P>0.05 ).Compared with the traditional endoscopy group,the PCSS group had significantly better results of the number of endoscopic treatment sessions ( t=-15.671 , P =0.001),the total amount of tissue adhesive used( t=-2.830 , P= 0.006),and the rate of alleviation or eradication ofvarices sclerosis( χ2 =7.078, P =0.029).Both groups had low rates of postoperativerebleeding,adversereactions,andcomplications,andtherewerensignificant diferences between the two groups (all P>0.05 ).ConclusionCompared with traditional endoscopy,PCSS can significantly enhance treatment outcome while maintaining safety standards.
Key Words:Esophageal and Gastric Varices;Echoendoscope;Embolization,Therapeutic; Treatment Outcome
Research funding:Beijing Municipal Administration of Hospitals Incubating Program(PX2023065)
食管胃靜脈曲張(gastroesophageal varices,GOV)破裂出血是肝硬化致死性并發(fā)癥[1]。(剩余10936字)
- 中西醫(yī)結(jié)合在慢加急性肝衰竭全病...
- 慢加急性肝衰竭的證候演變及證治...
- 中醫(yī)治療肝衰竭60年:從臨床洞...
- 新技術(shù)在慢加急性肝衰竭全病程管...
- 慢加急性肝衰竭預(yù)后評分模型和標(biāo)...
- 《2025年歐洲肝病學(xué)會臨床實...
- 《2025年亞太肝病學(xué)會臨床實...
- 《2025年美國胃腸病學(xué)院臨床...
- 調(diào)整抗病毒治療方案對慢性乙型肝...
- 1267例兒童慢性乙型肝炎患者...
- 臨床醫(yī)生對《慢性乙型肝炎防治指...
- 鹽酸可洛派韋聯(lián)合索磷布韋治療基...
- 血清肌酐/胱抑素C比值與成人非...
- 基于體檢人群調(diào)查代謝相關(guān)脂肪性...
- 抑制脯氨酰內(nèi)肽酶表達對非酒精性...
- 高代謝風(fēng)險慢性乙型肝炎患者發(fā)生...
- 超聲內(nèi)鏡下選擇性食管胃靜脈曲張...
- 經(jīng)頸靜脈肝內(nèi)門體分流術(shù)治療肝硬...
- 靶向葉酸受體 α(FRα) 的...
- 基于肌少癥的慢加急性肝衰竭患者...
- 細菌性肝膿腫并發(fā)膿毒癥的危險因...
- 肝豆?fàn)詈俗冃訩-F環(huán)分級與認知...
- 機器人胰腺實質(zhì)保留手術(shù)與腹腔鏡...
- 表觀遺傳學(xué)在瘦型非酒精性脂肪性...
- 脂肪量和肥胖相關(guān)基因在代謝相關(guān)...
- 衰老驅(qū)動代謝相關(guān)脂肪性肝病的機...
- 原發(fā)性膽汁性膽管炎合并干燥綜合...
- 胰島素樣生長因子-I(IGF-...
- 液體活檢在肝細胞癌診斷及治療中...
- 中藥調(diào)控腫瘤相關(guān)巨噬細胞對肝細...
- 代謝組學(xué)在中醫(yī)藥防治肝衰竭中的...
- 免疫分子及相關(guān)免疫細胞在肝衰竭...
- 基因修飾間充質(zhì)干細胞在肝臟疾病...
- 轉(zhuǎn)運RNA衍生小RNA(tsR...
- 吲哚菁綠熒光顯像技術(shù)在膽道閉鎖...
- Gut丨里程碑式突破!水稻“種...
- Gut|NLRP6缺失通過E-...
- HepatologyResea...
- HepatologyResea...
- JournalofGastro...
- 《臨床肝膽病雜志》對形態(tài)學(xué)圖片...
- 《臨床肝膽病雜志》論著類文章摘...
- 《臨床肝膽病雜志》2025年1...
- 《臨床肝膽病雜志》入展第三十一...
- 《臨床肝膽病雜志》被美國BIO...